483 filings
Page 13 of 25
8-K
pytoi ea5
13 May 11
Other Events
12:00am
8-K
il5 ka25weda
12 May 11
Departure of Directors or Certain Officers
12:00am
8-K
vk73u0q8
9 May 11
Alexza Reports 2011 First Quarter Financial Results and Provides Business Update
12:00am
424B5
mospditsm tq53fujzc8
3 May 11
Prospectus supplement for primary offering
12:00am
8-K
ei9b4c0
3 May 11
Alexza Prices $16.1 Million Registered Direct Offering
12:00am
CT ORDER
9gzaa i6mezf
1 Apr 11
Confidential treatment order
12:00am
424B3
mbiqrwy4 5di398
15 Mar 11
Prospectus supplement
12:00am
8-K
71nfis pwlr0zbh2otm
15 Mar 11
Alexza Reports 2010 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
12:00am
8-K
sj5co3x ncxbbxmjqe7
22 Feb 11
Departure of Directors or Certain Officers
12:00am
SC TO-I/A
b4wce gfbrgqvs7goz2
22 Feb 11
Issuer tender offer statement (amended)
12:00am
8-K
c7tozh
22 Feb 11
Entry into a Material Definitive Agreement
12:00am
8-K
k8y6l6
4 Feb 11
Departure of Directors or Certain Officers
12:00am
SC TO-I/A
cjw9e6138m6mponqa
28 Jan 11
Issuer tender offer statement (amended)
12:00am
SC TO-I
6kffg tkfdi
21 Jan 11
Issuer tender offer statement
12:00am
8-K
79cabu7lsut3pkddh
21 Jan 11
Departure of Directors or Certain Officers
12:00am
8-K
gq5azc5 9gf4h
18 Jan 11
Alexza Pharmaceuticals Completes End-of-Review Meeting with FDA for AZ-004 (Staccato® Loxapine) NDA
12:00am
EFFECT
imdjpkl mio63
11 Jan 11
Notice of effectiveness
12:00am